GO:1905368 peptidase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905368 (peptidase complex) is a cellular component defined as a protein complex capable of peptidase activity, including protease and tryptase complexes.
• Peptidase complexes such as the signal peptidase complex (SPC) and the 26S proteasome carry out essential proteolytic processing and degradation in eukaryotic cells.
• The human SPC is a multi-subunit membrane complex that cleaves signal peptides from secretory and membrane proteins, with subunits homologous to yeast SEC11.
• The 26S proteasome is a large peptidase complex that degrades ubiquitinated proteins and regulates many cellular processes.
• Peptidase complexes are implicated in cancer, neurodegeneration, and infectious diseases, making them important drug targets.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable functional dissection of peptidase complex subunits and their disease relevance.
Description
GO:1905368, peptidase complex, is a Gene Ontology cellular component term that describes any protein complex capable of peptidase activity. Peptidase complexes are molecular machines that hydrolyze peptide bonds, and they participate in a wide range of biological processes including protein maturation, quality control, and degradation. The term encompasses well-characterized assemblies such as the signal peptidase complex (SPC), the 26S proteasome, and the ClpP peptidase complex. Understanding peptidase complexes is fundamental for researchers studying proteostasis, signal peptide processing, and host-pathogen interactions. The SPC is a membrane-embedded complex that removes signal peptides from newly synthesized secretory and membrane proteins, a critical step in protein biogenesis. The 26S proteasome is a cytosolic and nuclear peptidase complex that degrades ubiquitinated proteins and controls the half-life of many regulatory proteins. Because peptidase complexes are involved in essential cellular functions, their dysfunction is linked to human diseases including cancer, neurodegeneration, and microbial infections. This article provides a research-grade overview of the peptidase complex (GO:1905368), covering its definition, composition, mechanisms, disease associations, and experimental models for study.
peptidase complex At A Glance
| GO ID | GO:1905368 |
|---|---|
| GO term | peptidase complex |
| Ontology | cellular_component |
| Synonym | protease complex, tryptase complex |
| Major function | Protein complex capable of peptidase activity, including signal peptide cleavage and protein degradation |
| Example complexes | Signal peptidase complex (SPC), 26S proteasome, ClpP peptidase complex |
| Subcellular location | Membrane (SPC), cytosol/nucleus (26S proteasome) |
| Related diseases | Cancer, neurodegeneration, bacterial infections |
What Is GO:1905368?
According to the Gene Ontology, GO:1905368 (peptidase complex) is defined as a protein complex which is capable of peptidase activity. This cellular component term includes any multi-subunit assembly that exhibits protease or tryptase activity, such as the signal peptidase complex and the 26S proteasome. The term is used to annotate gene products that are subunits of such complexes, and it is distinct from individual peptidase enzymes that are not part of a stable complex.
Why Is peptidase complex Important in Cell Biology?
Peptidase complexes are central to protein homeostasis and signaling, and their dysfunction contributes to a broad spectrum of human diseases. The signal peptidase complex is essential for the biogenesis of secretory and membrane proteins, and its inhibition or dysregulation can impair cell viability. The 26S proteasome controls the degradation of key regulatory proteins, and its inhibitors are used in cancer therapy. ClpP peptidase complexes are validated antibacterial targets, highlighting the clinical relevance of peptidase complexes in infectious diseases. Thus, studying GO:1905368 is critical for understanding fundamental cell biology and for developing therapeutic interventions.
• Peptidase complexes execute essential proteolytic processing and degradation reactions in all domains of life.
• The signal peptidase complex is required for the maturation of secretory and membrane proteins, affecting cell surface and secreted proteomes.
• The 26S proteasome regulates cell cycle, apoptosis, and immune responses by degrading ubiquitinated proteins.
• ClpP peptidase complexes are promising targets for novel antibiotics against drug-resistant bacteria.
• Peptidase complexes are implicated in cancer progression and neurodegeneration through altered proteostasis.
• MALDI-TOF mass spectrometry enables monitoring of peptidase activities in complex proteomes, aiding drug discovery.
• The COP9 signalosome, a peptidase-like complex, regulates cullin-RING ubiquitin ligases and is linked to cancer.
• α2-Macroglobulins regulate peptidase activity in plasma and tissues, influencing immune and coagulation pathways.
• SAGA chromatin-modifying complex contains peptidase-like subunits and connects proteolysis to transcription.
• CRISPR screens can identify essential peptidase complex subunits and their genetic interactions.
What Happens During peptidase complex?
Substrate Recognition and Binding
In simple terms: The peptidase complex first grabs the target protein or peptide.
Peptidase complexes recognize substrates through specific structural features, such as signal peptides in the case of the signal peptidase complex (SPC). The SPC binds to the signal peptide of nascent secretory proteins as they enter the endoplasmic reticulum membrane. In the 26S proteasome, substrate recognition is mediated by ubiquitin receptors that bind polyubiquitinated proteins. This step ensures that only appropriate substrates are processed or degraded.
Catalytic Cleavage of Peptide Bonds
In simple terms: The complex cuts the protein at a specific site.
Once bound, the peptidase complex catalyzes hydrolysis of peptide bonds using a catalytic triad or dyad in its active site. The SPC cleaves signal peptides at a defined position, releasing the mature protein. The 26S proteasome degrades substrates processively into short peptides. ClpP peptidase complexes also use a serine protease mechanism to cleave substrates.
Product Release and Recycling
In simple terms: After cutting, the products are released and the complex is ready for another round.
Following cleavage, the peptidase complex releases the products, which can be further processed or degraded. The SPC releases the mature protein into the secretory pathway, while the signal peptide is degraded. The 26S proteasome releases peptides that are subsequently hydrolyzed by cytosolic peptidases. The complex itself remains intact and can catalyze multiple rounds of cleavage.
Regulation by Accessory Factors
In simple terms: Other proteins can turn the complex on or off.
Peptidase complex activity is regulated by accessory proteins and post-translational modifications. The COP9 signalosome regulates the 26S proteasome and cullin-RING ligases through deneddylation. α2-Macroglobulins act as broad-spectrum peptidase inhibitors in plasma, trapping peptidases and preventing uncontrolled proteolysis. These regulatory mechanisms ensure that peptidase complexes act only when and where needed.
Key Genes Involved in GO:1905368 peptidase complex
The following genes encode subunits or regulators of peptidase complexes (GO:1905368) and are commonly studied in functional genomics and drug discovery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEC11A | Catalytic subunit of the signal peptidase complex | Essential for signal peptide cleavage; knockout causes secretory defects |
| SEC11C | Paralog of SEC11A in the signal peptidase complex | Tissue-specific functions; potential cancer target |
| SPCS1 | Subunit of the signal peptidase complex | Required for complex stability and activity |
| SPCS2 | Subunit of the signal peptidase complex | Mutations affect protein secretion |
| SPCS3 | Subunit of the signal peptidase complex | Interacts with viral proteins; host factor for flaviviruses |
| PSMA1 | Alpha subunit of the 20S proteasome | Core peptidase complex for protein degradation |
| PSMB5 | Beta subunit of the 20S proteasome | Target of bortezomib in cancer therapy |
| PSMC1 | AAA-ATPase subunit of the 19S regulatory particle | Required for substrate unfolding and translocation |
| CLPP | Catalytic subunit of the ClpP peptidase complex | Antibacterial target; essential in bacteria |
| CLPX | ATPase partner of ClpP | Regulates ClpP substrate selection |
| COPS5 | Subunit of the COP9 signalosome | Regulates cullin-RING ligases and proteasome activity |
| COPS6 | Subunit of the COP9 signalosome | Involved in deneddylation and cancer |
| A2M | Pan-peptidase inhibitor | Regulates peptidase activity in plasma |
| A2ML1 | Peptidase inhibitor | Associated with skin and immune disorders |
| SAGA complex subunits | Chromatin-modifying complex with peptidase-like domains | Links proteolysis to transcription |
| TMPRSS2 | Type II transmembrane serine protease | Forms peptidase complexes; drug target in viral entry |
| CTSL | Lysosomal cysteine peptidase | Involved in antigen presentation and cancer |
How Is peptidase complex Regulated?
Peptidase complex activity is regulated at multiple levels, including subunit expression, post-translational modifications, and interaction with inhibitors. The COP9 signalosome regulates the 26S proteasome by removing Nedd8 from cullins, thereby controlling substrate degradation. α2-Macroglobulins act as irreversible peptidase inhibitors in plasma, modulating proteolytic cascades. Additionally, phosphorylation and ubiquitination of peptidase complex subunits can alter their assembly and activity. These regulatory mechanisms ensure that peptidase complexes respond to cellular signals and maintain proteostasis.
peptidase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSMB5 | Multiple myeloma; proteasome inhibitor resistance | Point mutation knock-in in cancer cell lines |
| COPS5 | Breast cancer; cullin-RING ligase dysregulation | Knockout in breast cancer organoids |
| CLPP | Bacterial infections; antibiotic target | Knockout in S. aureus or E. coli |
| SEC11A | Secretory protein misfolding; cancer | Knockout in HEK293 or HeLa cells |
| A2M | Emphysema; peptidase imbalance | Overexpression in hepatocytes |
Peptidase Complexes in Cancer
Dysregulation of peptidase complexes is frequently observed in cancer. The 26S proteasome degrades tumor suppressors and cell cycle regulators, and its inhibitors are used to treat multiple myeloma. The COP9 signalosome regulates cullin-RING ligases that control oncoprotein stability, and its subunits are overexpressed in various cancers. Targeting peptidase complexes with small molecules or CRISPR screens can reveal cancer vulnerabilities.
Peptidase Complexes in Neurodegeneration
Impaired proteasome function contributes to the accumulation of misfolded proteins in neurodegenerative diseases such as Alzheimer's and Parkinson's. The signal peptidase complex is essential for neuronal membrane protein biogenesis, and its dysfunction may lead to ER stress. Modulating peptidase complex activity is a potential therapeutic strategy for neurodegeneration.
Peptidase Complexes in Infectious Diseases
Bacterial ClpP peptidase complexes are essential for virulence and survival, making them attractive antibiotic targets. In viruses, host peptidase complexes such as the signal peptidase complex are required for processing viral glycoproteins. Inhibitors of these complexes can block viral replication and bacterial growth.
From peptidase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SEC11A essential for cell viability? | CRISPR knockout in HEK293T cells |
| Does a PSMB5 mutation confer bortezomib resistance? | Point mutation knock-in in RPMI-8226 cells |
| Can CLPP be targeted by novel antibiotics? | Knockout in S. aureus and mouse infection model |
| How does COPS5 regulate cullin neddylation? | Knock-in of tagged COPS5 in U2OS cells |
| Does A2M overexpression protect against peptidase damage? | Overexpression in mouse liver |
| What is the subcellular localization of SPCS3? | Knock-in of GFP-SPCS3 in HeLa cells |
How to Study the peptidase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| MALDI-TOF MS | Peptidase activity in complex proteomes | Drug screening and substrate profiling |
| CRISPR knockout screen | Gene essentiality and resistance | Identify peptidase complex subunits |
| Cryo-EM | 3D structure of peptidase complexes | Mechanistic studies and inhibitor design |
| Co-immunoprecipitation | Protein-protein interactions | Define complex composition |
| Western blot | Subunit expression and cleavage | Validate knockout or overexpression |
| Fluorescence microscopy | Subcellular localization | Track tagged subunits in live cells |
| RNA-seq | Transcriptional changes | Assess cellular response to peptidase inhibition |
| Ubiquitin chain profiling | Proteasome substrate accumulation | Measure proteasome activity |
Mass Spectrometry-Based Peptidase Activity Profiling
MALDI-TOF mass spectrometry can monitor peptidase activities in complex proteomes, allowing researchers to profile substrate cleavage in cell lysates. This method is useful for identifying specific peptidase complex substrates and for screening inhibitors.
CRISPR Library Screening
Genome-wide CRISPR knockout screens can identify genes required for peptidase complex function or resistance to peptidase inhibitors. Such screens have revealed essential subunits of the signal peptidase complex and ClpP.
Structural Biology and Cryo-EM
Cryo-electron microscopy has been used to determine the structure of the human signal peptidase complex, revealing determinants for signal peptide cleavage. Structural studies guide the design of inhibitors targeting peptidase complexes.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify subunits and interactors of peptidase complexes. This approach helps define the composition of GO:1905368 complexes in different cell types.
How CRISPR Can Be Used to Study GO:1905368 peptidase complex
Knockout
CRISPR knockout of peptidase complex subunits such as SEC11A or PSMB5 can reveal essential functions in protein secretion and degradation. Knockout cell lines are valuable for studying substrate accumulation and compensatory pathways.
Point Mutation
Point mutations in catalytic residues of peptidase complex subunits, such as the active-site serine of SEC11A, can be introduced to dissect catalytic versus non-catalytic functions. Such models help distinguish between proteolytic and scaffolding roles.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous peptidase complex genes enables real-time imaging and affinity purification. Tagged knock-in models are useful for studying complex assembly and dynamics.
Overexpression
Overexpression of peptidase complex subunits or inhibitors such as A2M can model gain-of-function states and test therapeutic hypotheses. Overexpression models are particularly useful for studying peptidase imbalance in disease.
How EDITGENE Supports peptidase complex Research
Researchers studying peptidase complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate processing, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for peptidase complex research.
Frequently Asked Questions About peptidase complex
What is GO:1905368 peptidase complex?
GO:1905368 is a Gene Ontology cellular component term defined as a protein complex capable of peptidase activity, including protease and tryptase complexes.
What genes are involved in peptidase complex?
Key genes include SEC11A, SEC11C, SPCS1, SPCS2, SPCS3, PSMA1, PSMB5, PSMC1, CLPP, CLPX, COPS5, COPS6, A2M, and A2ML1.
What is the function of the signal peptidase complex?
The signal peptidase complex cleaves signal peptides from newly synthesized secretory and membrane proteins, a critical step in protein maturation.
How is the 26S proteasome related to peptidase complex?
The 26S proteasome is a peptidase complex that degrades ubiquitinated proteins and regulates many cellular processes.
What diseases are associated with peptidase complex dysfunction?
Peptidase complex dysfunction is linked to cancer, neurodegeneration, and infectious diseases.
How can I study peptidase complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of peptidase complex subunits and their disease relevance.
What methods are used to measure peptidase complex activity?
MALDI-TOF mass spectrometry, activity-based probes, and ubiquitin chain profiling are commonly used.
Is the signal peptidase complex a drug target?
Yes, the signal peptidase complex is a potential target for antiviral and anticancer therapies.
What is the role of ClpP peptidase complex in bacteria?
ClpP is a serine peptidase complex essential for bacterial virulence and is a promising antibiotic target.
How does the COP9 signalosome regulate peptidase complexes?
The COP9 signalosome regulates cullin-RING ligases and the 26S proteasome through deneddylation.
Conclusion
GO:1905368 (peptidase complex) represents a diverse group of multi-subunit molecular machines that carry out essential proteolytic reactions in cells. From signal peptide cleavage by the SPC to protein degradation by the 26S proteasome, these complexes are central to proteostasis and signaling. Their dysfunction is implicated in cancer, neurodegeneration, and infectious diseases, making them important therapeutic targets. CRISPR-based models and advanced proteomic methods provide powerful tools to study peptidase complex biology and to develop new drugs. Continued research on GO:1905368 will deepen our understanding of cellular proteolysis and open new avenues for disease intervention.
References
- 1. Liaci AM et al.. 2021. Structure of the human signal peptidase complex reveals the determinants for signal peptide cleavage.. Mol Cell 81(19):3934-3948.e11 PMID: 34388369
- 2. Kato JY et al.. 2009. Mammalian COP9 signalosome.. Genes Cells 14(11):1209-25 PMID: 19849719
- 3. Villanueva J et al.. 2009. Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry.. Nat Protoc 4(8):1167-83 PMID: 19617888
- 4. Bhardwaj S et al.. 2024. ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics.. Curr Drug Targets 25(2):108-120 PMID: 38151841
- 5. Soffers JHM et al.. 2020. The SAGA chromatin-modifying complex: the sum of its parts is greater than the whole.. Genes Dev 34(19-20):1287-1303 PMID: 33004486
- 6. Shelness GS et al.. 1990. Two subunits of the canine signal peptidase complex are homologous to yeast SEC11 protein.. J Biol Chem 265(16):9512-9 PMID: 2188978
- 7. Garcia-Ferrer I et al.. 2017. α(2)-Macroglobulins: Structure and Function.. Subcell Biochem 83:149-183 PMID: 28271476
- 8. Coux O. 2002. The 26S proteasome.. Prog Mol Subcell Biol 29:85-107 PMID: 11908074
